The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTmt Investments Regulatory News (TMT)

Share Price Information for Tmt Investments (TMT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.62
Bid: 3.52
Ask: 3.72
Change: 0.00 (0.00%)
Spread: 0.20 (5.682%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.62
TMT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

21 Apr 2015 07:00

RNS Number : 7600K
TMT Investments PLC
21 April 2015
 

21 April 2015

 

TMT INVESTMENTS PLC

("TMT" or the "Company")

 

Final results for the year ended 31 December 2014

 

TMT Investments PLC, which invests in high-growth, internet-based companies across a variety of sectors, is pleased to announce its final results for the year ended 31 December 2014.

 

· US$1.36 NAV per share (up from US$1.30 as of 31 December 2013)

· TMT has now invested in just under 40 companies since its floatation in December 2010

· Diversified portfolio of investees focused around mobile software applications, cloud solutions, advertising technologies, social discovery shopping, and business SaaS tools

· Successful capital raise of US$2.65 million at US$1.85 per share

· US$3.37 million invested in eleven new companies

· Additional US$0.95 million invested in four existing portfolio companies

· A number of significant positive portfolio revaluations expected in 2015

 

Alexander Selegenev, Executive Director of TMT, commented:

 

"2014 was our fourth full year as a publicly traded company. During the year, we reviewed dozens of opportunities and invested US$3.37 million in eleven new companies. Our current portfolio includes 32 investees, providing a good level of diversification.

 

In 2014, the portfolio had one profitable cash exit (The One-Page Company, Inc.), two positive non-cash revaluations (Gild, Inc. and Backblaze, Inc.), one impairment (Graphicly, Inc.) and one negative non-cash revaluation (UsingMiles, Inc.).

 

Although 2014 turned out relatively uneventful for TMT in terms of number of exits and revaluations, a significant number of our portfolio companies have experienced rapid growth. In addition, a number of our investees are currently in the process of completing follow-on capital raises at notably higher valuation levels, so we expect a number of positive revaluations of our portfolio holdings in 2015. At the same time, given the risky nature of earlier-stage venture capital investments, we expect some negative revaluations in due course as well.

 

We continue to see exciting investment opportunities in our sector and look forward to updating our shareholders on the Company's progress in the near future."

 

The Annual Report and Accounts for the year ended 31 December 2014 are available on the Company's website at www.tmtinvestments.com, where an electronic copy can be accessed.

 

For further information contact:

 

TMT Investments Plc

Mr. Alexander Selegenev

www.tmtinvestments.com

 

+44 1534 281 843

alexander.selegenev@tmtinvestments.com

 

ZAI Corporate Finance Ltd.

NOMAD and Broker

Richard Morrison/Irina Lomova

 

+44 20 7060 2220

Kinlan Communications

David Hothersall

 

Tel. +44 20 7638 3435

davidh@kinlan.net

 

EXECUTIVE DIRECTOR'S STATEMENT

 

2014 has been a relatively quiet year for the Company, with only a limited number of revaluations across our portfolio. As a result, our NAV per share as of 31 December 2014 increased only slightly to US$1.36 (from US$1.30 as of 31 December 2013). TMT has now invested in just under 40 companies since its floatation in December 2010 and has a diversified portfolio of investees focused around mobile software applications, cloud solutions, advertising technologies, social discovery shopping and business SaaS tools.

 

Portfolio Performance

 

Similarly to previous years, the biggest "reporting challenge" faced by the Company in 2014 was due to the fact that the majority of our investments are made in earlier-stage, privately held companies, which do not have a sufficiently long history of earnings. This means that, regardless of how impressively (or otherwise) some of our portfolio companies may have grown in terms of revenue and operating metrics, changes in fair value of our portfolio companies cannot be justified under the IFRS rules unless there has been an independent equity financing round or other measurable reliable evidence to support a change in the valuation. We hope that the growing number of investee companies will increase the chances of more regular revaluations across our portfolio in the future.

 

In 2014, the following developments took place in the Company's portfolio:

 

Cash and part-cash exits:

 

· In August 2014, the Company sold its entire equity stake in The One-Page Company, Inc. ("One-Page"). TMT's total consideration received pursuant to the transaction was US$509,740, representing an internal rate of return ("IRR") of 32%. TMT originally invested US$250,000 in One-Page in February 2012.

 

Positive non-cash revaluations:

 

· In May 2014, Gild, Inc. ("Gild"), a proprietary IT talent sourcing and candidate relationship management platform, completed a new equity financing round. The transaction represents an uplift of approximately US$379,000 (or 223%) in the fair value of TMT's investment in Gild, compared to the amount reported as of 31 December 2013.

· Based on the results of an independent valuation report commissioned by Backblaze, Inc. ("Backblaze"), the fair value of TMT's equity stake in Backblaze has increased by approximately US$1.19 million (or 24%), compared to the amount reported as of 31 December 2013.

 

Impairments and write-offs:

 

· In May 2014, Graphicly, Inc. ("Graphicly"), an e-book publishing and distribution platform, announced its decision to wind up its operations. As a result, the fair value of TMT's investment in Graphicly has reduced by approximately US$345,000 (or 70%), compared to the amount reported as of 31 December 2013.

 

Negative non-cash revaluations:

 

· In October 2013, Universal Points Exchange, LLC, a wholly owned subsidiary of Source, Inc. ("Source") and Help Worldwide, Inc. ("HelpWW"), agreed to acquire the assets of UsingMiles Inc. ("UM") for shares. A UM liquidating trust ("Trust") has been established for the purposes of the transaction. The transaction closed on 31 December 2013, and TMT agreed to be included in the Trust on 11 August 2014. The transaction represents a reduction of approximately US$230,000 (or 89%) in the fair value of TMT's investment in UM, compared to the amount reported as of 31 December 2013.

 

Key developments for the 10 largest portfolio holdings in 2014 (compared to 2013; source: TMT's portfolio companies)

 

Adinch (online advertising platform):

· Joined the Plug and Play incubator program in the USA

· Six new advertising platforms integrated

· US$1.7m new equity raised

 

Anews (news reading app):

· Monthly active users up 301%

· Over 2m total app downloads

· Reached top 3 in the "News" category in AppStore and Google Play

· Monetization started in Q4 2014

· US$2.7m new equity raised

 

AppsIndep (online games developer):

· Revenues below expectations

· Seeking additional capital

 

Backblaze (online data backup provider):

· Revenues up 43%

· Total number of licensed computers up 54%

 

Depositphotos (photobank):

· Revenues up 42%

· Total number of authors up 19%

· Total number of files in the photobank up 50%

 

Pipedrive (sales CRM software):

· Revenues up 115%

· Total paying customers up 118%

 

rollApp (provider of access to 3rd party apps from any browser):

· Total applications available on the platform up 100%

· Premium subscription plan launched

· Several file storage services integrated

· "Awesome File Opener" plugin for Chrome and Mozilla browsers released

 

Unicell (Provider of digital marketing solutions and mobile applications and services):

· Remained marginally profitable, but highly overleveraged

 

Wanelo (online social shopping platform):

· Over 350,000 stores and 20 million products on the platform

· Total subscribers up 27%

· In-app purchases launched

 

Wrike (project management and collaboration software):

· Revenues up 107%

· Total number of paid accounts up 47%

 

New investments

 

In 2014 the Company invested US$3.37 million in eleven new companies (technology developer for visually impaired people PROvision/Oriense; smartphone solution provider for senior citizens E2C; mobile tech discovery service Drippler; on-demand business research platform Whale Path; "Internet of Everything" software developer Weaved; business productivity SaaS provider PandaDoc; fashion rental platform for women Le Tote; news reading app Anews; social intelligence platform Twtrland; mobile interface app Drupe; and taxi booking app Taxify), as well as an additional US$950,000 in four existing portfolio companies (Gentoo/Contacts+, rollApp, KitApps/Attendify, and Adinch).

 

NAV per share

 

The Company's net asset value per share as of 31 December 2014 increased to US$1.36 (31 December 2013: US$1.30).

 

Operating Expenses

 

In 2014, the Company's Administrative Expenses of US$1,382,874 were generally in line with 2013 levels (US$1,293,538). Total Operating Expenses decreased in the reporting period due to the lower share-based option charge of US$166,282 (2013: US$576,207). This is a non-cash item resulting from the Company's share option program adopted in October 2012.

 

Financial position

 

In July 2014, TMT raised US$2.65 million at US$1.85 per share from a number of new and existing investors. As of 31 December 2014, the Company had US$2.6 million in cash reserves. As of the date of this report, the Company has no debt and approximately US$2 million in cash reserves.

 

Events after the reporting period

 

In February 2015, TMT's portfolio company Drippler, a mobile tech discovery service, completed a new sizable equity financing round. The transaction represents an uplift of approximately US$97,000 (or 48%) in the fair value of TMT's investment in Drippler, compared to the amount announced as of 30 June 2014.

 

In April 2015, the Company invested US$300,000 in fragrance subscription service ScentBird.

 

Outlook

 

Although 2014 turned out relatively uneventful for TMT in terms of number of exits or revaluations, a significant number of our portfolio companies have experienced rapid growth. In addition, a number of our investees are currently in the process of completing follow-on capital raises at notably higher valuation levels, so we expect a number of positive revaluations of our portfolio holdings in 2015. At the same time, given the risky nature of earlier-stage venture capital investments, we expect some negative revaluations in due course as well.

 

We look forward to updating our shareholders on the Company's progress in the near future.

 

Alexander Selegenev

Executive Director

 

 

Statement of Comprehensive Income

 

 

For the year ended 31/12/2014

For the year ended 31/12/2013

Notes

USD

USD

Losses on investments

3

(23,911)

(29,593)

(23,911)

(29,593)

Expenses

Share-based payment charge

 

15

 

(166,282)

 

(576,207)

Administrative expenses

5

(1,382,874)

(1,293,538)

Operating loss

(1,573,067)

(1,899,338)

Net finance income

7

11,079

50,035

Loss before taxation

(1,561,988)

(1,849,303)

Taxation

8

-

-

Loss attributable to equity shareholders

(1,561,988)

(1,849,303)

Other comprehensive income for the year:

Change in fair value of available-for-sale financial assets

16

2,171,251

5,932,139

Total comprehensive income for the year

609,263

4,082,836

Loss per share

Basic and diluted loss per share (cents per share)

9

(5.96)

(7.42)

 

 

Statement of Financial Position

 

 

At 31 December

2014

USD

At 31 December

2013

USD

Notes

Non-current assets

Investments in equity shares

10

31,854,151

26,932,335

Convertible loan notes receivable

10

3,091,702

2,193,304

Total non-current assets

34,945,853

29,125,639

Current assets

Trade and other receivables

11

159,784

79,532

Cash and cash equivalents

12

2,639,070

3,242,269

Total current assets

2,798,854

3,321,801

Total assets

37,744,707

32,447,440

Current liabilities

Trade and other payables

13

59,399

96,008

Total liabilities

59,399

96,008

Net assets

37,685,308

32,351,432

Equity

Share capital

14

31,453,510

26,895,179

Share-based payment reserve

16

392,659

695,970

Fair value reserve

16

10,108,618

7,937,367

Retained losses

16

(4,269,479)

(3,177,084)

Total equity

37,685,308

32,351,432

 

 

Statement of Cash Flows

 

 

For the year

ended

31/12/2014

For the year ended 31/12/2013

 

USD

USD

 

Notes

 

Operating activities

 

Operating loss

(1,573,067)

(1,899,338)

 

Adjustments for non-cash items:

 

Profit on disposal of available-for-sale assets

3

(355,010)

(320,563)

Gain on conversion of loan notes to equity

(2,221)

(92,841)

Impairment of available-for-sale assets and accrued interest

3

451,482

458,863

Employee salaries settled by issue of shares

14

300,000

300,000

 

Share-based payment charge

15

166,282

576,207

 

Amortized costs of convertible notes receivable

3

14,036

28,263

 

(998,498)

(949,409)

 

Changes in working capital:

 

(Increase)/decrease in trade and other receivables

11

(80,252)

56,276

 

Decrease in trade and other payables

13

(36,609)

(18,307)

 

Net cash used by operating activities

(1,115,359)

 

(911,440)

 

Investing activities

 

Interest received

7

11,079

50,035

 

Purchase of available-for-sale assets

10

(4,370,612)

(5,412,720)

 

Proceeds from sale of available-for-sale assets

613,362

1,339,909

 

Net cash used by investing activities

(3,746,171)

 

(4,022,776)

 

Financing activities

 

Cash proceeds from issue of shares

14

4,258,331

1,158,930

 

Purchase of own shares

-

(699,999)

 

Net cash from financing activities

4,258,331

 

458,931

 

Decrease in cash and cash equivalents

(603,199)

 

(4,475,285)

 

Cash and cash equivalents at the beginning of the year

3,242,269

 

7,717,554

 

Cash and cash equivalents at the end of the year

12

2,639,070

 

3,242,269

 

 

Statement of Changes in Equity

 

For the year ended 31 December 2014 and for year ended 31 December 2013, USD

 

 

Share capital

Share-based payment reserve

Fair value reserve

Retained losses

Total

Notes

USD

USD

USD

USD

USD

Balance at 1 January 2013

26,136,248

128,183

2,005,228

(1,336,201)

26,933,458

 

Total comprehensive income/(loss) for the year

-

-

5,932,139

(1,849,303)

4,082,836

Issue of shares

14

1,458,930

-

-

-

1,458,930

Buy back and cancellation of shares

(699,999)

-

-

-

(699,999)

Share-based payment charge

15

-

576,207

-

-

576,207

Lapse of share options

15

-

(8,420)

-

8,420

-

Balance at 31 December 2013

26,895,179

695,970

7,937,367

(3,177,084)

32,351,432

 

Total comprehensive income/(loss) for the year

-

-

2,171,251

(1,561,988)

609,263

Issue of shares

14

4,558,331

-

-

-

4,558,331

Share-based payment charge

15

-

166,282

-

-

166,282

Transfers on exercise / lapse of share options

15

-

(469,593)

-

469,593

-

Balance at 31 December 2014

31,453,510

392,659

10,108,618

(4,269,479)

37,685,308

 

 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2014

 

1. Company information

 

TMT Investments Plc ("TMT" or the "Company") is a company incorporated in Jersey with its registered office at Queensway House, Hilgrove Street, St Helier, JE1 1ES, Channel Islands.

 

The Company was incorporated and registered on 30 September 2010 in Jersey under the Companies (Jersey) Law 1991 with registration number 106628 under the name TMT Investments Limited. The Company obtained consent from the Jersey Financial Services Commission pursuant to the Control of Borrowing (Jersey) Order 1985 on 30 September 2010. On 1 December 2010 the Company re-registered as a public company and changed its name to TMT Investments PLC.

 

The memorandum and articles of association of the Company do not restrict its activities and therefore it has unlimited legal capacity. The Company's ability to implement its Investment Policy and achieve its desired returns will be limited by its ability to identify and acquire suitable investments. Suitable investment opportunities may not always be readily available.

 

The Company will seek to make investments in any region of the world.

 

Financial statements of the Company are prepared by and approved by the Directors in accordance with International Financial Reporting Standards, International Accounting Standards and their interpretations issued or adopted by the International Accounting Standards Board as adopted by the European Union ("IFRSs"). The Company's accounting reference date is 31 December.

 

2. Summary of significant accounting policies

 

2.1 Basis of presentation

 

The principal accounting policies applied by the Company in the preparation of these financial statements are set out below and have been applied consistently.

 

The financial statements have been prepared on a going concern basis, under the historical cost basis as modified by the fair value of available-for-sale financial assets, as explained in the accounting policies below, and in accordance with IFRS. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

 

2.2 Going concern

 

The Directors confirm that, after giving due consideration to the financial position and expected cash flows of the Company; they have a reasonable expectation that the Company will have adequate cash resources to continue in operational existence for the foreseeable future, and for at least one year from the date of approval of these financial statements and they have therefore adopted the going concern basis in preparing the financial statements.

 

2.3 Segmental reporting

 

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker who is responsible for allocating resources and assessing performance of the operating segments and which has been identified as the Board of Directors that make strategic decisions. For the purposes of IFRS 8 'Operating Segments' the Company currently has one segment, being 'Investing in the TMT sector'.

 

Even though the Company only has one segment, there are still geographical disclosures that need to be made to comply with IFRS 8 'Operating Segments'.

 

The Company analyses revenue and non-current financial assets according to the geographical location of the investment (see note 4).

 

2.4 Foreign currency translation

 

(a) Functional and presentation currency

Items included in the financial statements of the Company are measured in United States Dollars ('US dollars', 'USD' or 'US$'), which is the Company's functional and presentation currency.

 

(b) Transactions and balances

Foreign currency transactions are translated into US$ using the exchange rates prevailing at the dates of the transactions. Exchange differences arising from the translation at the year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the statement of comprehensive income.

 

Conversation rates, USD

Currency

At 31.12.2014

Average rate, 2014

British pounds, £

1.5569

1.6478

Euro, €

1.2162

1.3258

 

2.5 Cash and cash equivalents

 

Cash and cash equivalents consist of cash at bank and in hand, deposits held at call with banks, bank overdrafts and other short-term highly liquid investments with maturities of three months or less from the date of acquisition.

 

2.6 Financial assets

 

Recognition and measurement

Investments are recognized and de-recognized on a date where the purchase or sale of an investment is under a contract whose terms require the delivery or settlement of the investment. The Company manages its investments with a view to profiting from the receipt of dividends and changes in fair value of equity investments.

 

"Available-for-sale" financial instruments include unlisted equity investments and convertible promissory loan notes. Equity instruments classified as available-for-sale are those which are neither classified as held-for-trading nor designated as fair value through profit or loss. Convertible promissory loan notes are treated as similar in nature to the unlisted equity investments and designated as available-for-sale.

 

Available-for-sale investments are carried at fair values except for financial assets that do not have a quoted market price in an active market and whose fair value cannot be reliably measured which are measured at cost less any identified impairment losses at the end of the period in accordance with the IAS 39 para 46 (c) exemptions. Fair value information has therefore not been disclosed for those investments.

 

Where there has been a relevant transaction during the year that gives an indication of the fair value of the available-for-sale unlisted shares, the shares are included at that fair value and the increase or decrease in fair value is recognised in the investment fair value reserve. The "price of recent investment" methodology is used mainly for investments in venture capital companies and includes cost of investment or valuation by reference to a subsequent financing round. Valuation increases above cost are only recognised if that round involved a new external investor and the company is meeting milestones set by investors.

 

Investments are classified on recognition as "fair value through profit and loss" when their fair values can be estimated reliably on a regular basis and when they are managed on a fair value basis. Fair value changes of investments at fair value through profit and loss are included within profit/loss in the income statement. At 31 December 2014 all investments are classified as "available-for-sale" and none are classified as "fair value through profit and loss".

 

Financial assets that qualify as an associate as 20% or more of the voting rights are held by the company, are exempt from IAS 28 'Investments in Associates', as TMT Investments plc is a venture capital organisation. Such investments are therefore treated as available-for-sale financial assets.

 

Income

Interest income from convertible notes receivable is recognized as it accrues by reference to the principal outstanding and the effective interest rate applicable, which is the rate that exactly discounts the estimated future cash flows through the expected life of the financial asset to the asset's carrying value.

 

Impairment of available-for-sale financial assets

A financial asset is considered to be impaired if objective evidence indicates that one or more events have had a negative effect on the estimated future cash flows of that asset. In case of available for sale assets, a significant or prolonged decline in the fair value of the financial asset below its cost is considered an indicator that the financial assets are impaired.

 

If objective evidence indicates that financial assets that are carried at cost need to be tested for impairment, calculations are based on information derived from business plans and other information available for estimating their fair value. Any impairment loss is included in profit/loss for the year in the Statement of Comprehensive Income.

 

2.7 Net finance income

 

Net finance income comprises interest income on deposits. Interest income is recognized as it accrues in the statement of comprehensive income, using the effective interest method. Finance costs comprise interest expenses on borrowings and the unwinding of the discount on provisions.

 

2.8 Taxation

 

Deferred tax is provided in full using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that, at the time of the transaction, affects neither accounting nor taxable profit or loss. Deferred tax is determined using tax rates that are expected to apply when the related deferred tax asset is realised or when the deferred tax liability is settled. Deferred tax assets are recognised to the extent that it is probable that future taxable profits will be available against which the temporary differences can be utilised.

 

2.9 Equity instruments

 

Ordinary shares are classified as equity. Costs directly attributable to the issue of new shares are shown in equity as a deduction from the proceeds.

 

2.10 Share-based payments

 

The fair value of options granted to employees is recognized as an employee expense, with a corresponding increase in equity, over the period that the employees become unconditionally entitled to the options. The amount recognized as an expense is adjusted to reflect the actual number of share options that vest. For equity settled share-based payment transactions other than transactions with employees the Company measures the goods or services received at their fair value, unless that fair value cannot be estimated reliably. If this is the case the Company measures their fair values and the corresponding increase in equity, indirectly, by reference to the fair value of equity instruments granted.

 

The Company enters into arrangements that are equity-settled share-based payments with certain employees. These are measured at fair value at the date of grant, which is then recognized in the statement of comprehensive income on a straight-line basis over the vesting period, based on the Company's estimate of shares that will eventually vest. Fair value is measured by use of an appropriate model. In valuing equity-settled transactions, no account is taken of any vesting conditions, other than conditions linked to the price of the shares of TMT Investments. The charge is adjusted at each year end date to reflect the actual number of forfeitures, cancellations and leavers during the period. The movement in cumulative charges since the previous year end is recognized in the statement of comprehensive income, with a corresponding entry in equity.

 

2.11 New IFRSs and interpretations not applied

 

The IASB has issued the following standards and interpretations which have been endorsed by the European Union to be applied to financial statements with periods commencing on or after the following dates:

 

Effective for period beginning on or after

IFRS 9

Financial Instruments

1 January 2018

IFRS 10

Consolidated Financial Statements

1 January 2014

IFRS 11

Joint Arrangements

1 January 2014

IFRS 12

Disclosure of Interests in Other Entities

1 January 2014

IFRS 13

Fair Value Measurement

1 January 2014

IFRS 15

Revenue from Contracts with Customers

1 January 2017

IAS 27

Separate Financial Statements (2011)

1 January 2014

IAS 28

Investments in Associates and Joint Ventures (2011)

1 January 2014

IAS 32

Amendments to IAS 32 Disclosures - Offsetting Financial Assets and Financial Liabilities

1 January 2014

IAS 36

Amendments to IAS 36 - Recoverable Amount Disclosures for Non-Financial Assets

1 January 2014

 

There is no material impact on the financial statements of the application of new standards with an effective date of 1 January 2014. The Directors do not anticipate that the adoption of other standards and interpretations will have a material impact on the financial statements in the period of initial application and have decided not to adopt any of them early.

 

2.12 Accounting estimates and judgements

 

Estimates and judgements need to be regularly evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. The Company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, rarely equal the related actual results.

 

The estimates and underlying assumptions are reviewed on an on-going basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.

 

The estimates significant to the financial statements during the year and at the year-end is the consideration of the fair value of available-for-sale assets, the impairment of available-for-sale assets and share-based payment calculations, as set out in the relevant accounting policies shown above. A number of the available-for-sale financial assets held by the Company are at an early stage of their development. The Company cannot yet carry out regular reliable fair value estimates of some of these investments. Future events or transactions involving the companies invested in may result in more accurate valuations of their fair values (either upwards or downwards) which may affect the Company's overall net asset value.

 

3 Losses on investments

 

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Gross interest income from convertible notes receivable

86,597

136,970

Amortized costs of convertible notes receivable

(14,036)

(28,263)

Net interest income from convertible notes receivable

72,561

108,707

Profit on disposal of equity investments

251,388

-

Profit on disposal of convertible notes

103,622

320,563

Impairment of available-for-sale assets

(451,482)

(390,683)

Impairment of interest accrued

-

(68,180)

Total net losses on investments

(23,911)

(29,593)

 

4 Segmental analysis

 

Geographic information

The Company has investments in six principal geographical areas - USA, Israel, BVI, Estonia, Cyprus, and Russia.

 

Non-current financial assets

 

As at 31/12/2014

USA

Israel

BVI

Cyprus

Estonia

Russia

Total

USD

USD

USD

USD

USD

USD

USD

Equity investments

25,490,710

3,806,652

305,050

1,863,685

328,958

59,096

31,714,151

Convertible notes

2,954,852

-

-

-

136,850

-

3,091,702

 Total

28,445,562

3,806,652

305,050

1,863,685

465,808

59,096

34,945,853

 

As at 31/12/2013

USA

USD

Israel

USD

BVI

USD

Cyprus

USD

Estonia

USD

Total

USD

Equity investments

21,781,129

2,982,471

305,050

1,863,685

-

26,932,335

Convertible notes

2,051,605

-

-

-

141,699

2,193,304

Total

23,832,734

2,982,471

305,050

1,863,685

141,699

29,125,639

 

5 Administrative expenses

 

Administrative expenses include the following amounts:

 

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Staff expenses (note 6)

796,309

718,030

Professional fees

173,963

177,365

Legal fees

27,266

56,341

Bank and LSE charges

24,412

26,118

Audit and accounting fees

49,837

43,281

Rent

172,608

172,608

Other expenses

119,717

106,709

Currency exchange loss/(gain)

18,762

(6,914)

1,382,874

1,293,538

 

6 Staff expenses

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Directors' fees

356,269

268,283

Wages and salaries

440,040

449,747

796,309

718,030

 

Wages and salaries shown above include salaries and bonuses relating to 2014. These costs are included in administrative expenses. As discussed in note 14, wages and salaries include US$300,000 of employee salaries that were settled by the issue of shares in lieu of cash payments. In addition to the above, there are employment expenses for share-based payments of US$166,282 (for the year ended 31 December 2013: $576,207).

 

The average number of staff employed (excluding Directors) by the Company during the year was 5 (2013: 5).

 

The Directors' fees (including bonuses where applicable) for 2014 were as follows:

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Alexander Selegenev

186,826

110,852

Yuri Mostovoy

115,500

100,000

James Joseph Mullins

32,912

31,161

Petr Lanin

21,031

26,270

356,269

268,283

 

The Directors' fees shown above are all classified as 'short term employment benefits' under International Accounting Standard 24. The Directors do not receive any pension contributions or other benefits.

 

Key management personnel of the Company are defined as those persons having authority and responsibility for the planning, directing and controlling the activities of the Company, directly or indirectly. Key management of the Company are therefore considered to be the Directors of the Company. There were no transactions with the key management, other than their Directors fees, bonuses and share options.

 

7 Net finance income

 

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Interest income

11,079

50,035

11,079

50,035

 

8 Income tax expense

 

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Current taxes

Current year

-

-

Deferred taxes

Deferred income taxes

-

-

-

-

The Company is incorporated in Jersey. No tax reconciliation note has been presented as the income tax rate for Jersey companies is 0%.

 

9 Loss per share

 

The calculation of basic loss per share is based upon the net loss for the year ended 31 December 2014 attributable to the ordinary shareholders of US$1,561,988 (2013: net loss of US$1,849,303) and the weighted average number of ordinary shares outstanding calculated as follows:

 

Loss per share

For the year ended 31/12/2014

For the year ended 31/12/2013

Basic loss per share (cents per share)

(5.96)

(7.42)

Loss attributable to equity holders of the entity

(1,561,988)

(1,849,303)

 

The weighted average number of ordinary shares outstanding before and after adjustment for the effects of all dilutive potential ordinary shares calculated as follows:

(in number of shares weighted during the year outstanding)

For the year ended 31/12/2014

For the year ended 31/12/2013

Weighted average number of shares in issue

Ordinary shares

26,199,590

24,914,735

26,199,590

24,914,735

Effect of dilutive potential ordinary shares

Share options

1,004,720

1,042,733

Weighted average of shares for the year (fully diluted)

27,204,310

25,957,468

 

The diluted loss per share for both 2014 and 2013 is kept the same as the basic loss per share because the conversion of the share options decreases the basic loss per share and is therefore anti-dilutive.

 

10 Non-current financial assets

 

At 31 December 2014

At 31 December 2013

Available-for-sale financial assets, USD:

Investments in equity shares (i)

- unlisted shares

31,854,151

26,932,335

Convertible notes receivable (ii)

- promissory notes

3,091,702

2,193,304

34,945,853

29,125,639

 

Reconciliation of fair value measurements of non-current financial assets:

 

Available-for-sale

Total

Unlistedshares

Convertiblenotes

USD

USD

USD

Balance as at 1 January 2013

15,434,540

3,691,691

19,126,231

Total gains or losses in 2013:

- in profit or loss - impairment

-

(390,683)

(390,683)

- in other comprehensive income

5,932,139

-

5,932,139

Purchases (including consulting & legal fees)

3,582,550

1,830,170

5,412,720

Disposal of investment (carrying value)

-

(1,047,609)

(1,047,609)

Conversion of notes to equity and net gain

1,983,106

(1,890,265)

92,841

Balance as at 31 December 2013

26,932,335

2,193,304

29,125,639

Total gains or losses in 2014:

- in profit or loss - impairment

(451,482)

-

(451,482)

- in other comprehensive income

2,171,251

-

2,171,251

Purchases (including consulting & legal fees)

3,074,752

1,295,860

4,370,612

Disposal of investment (carrying value)

(258,352)

(14,036)

(272,388)

Conversion and other movements

385,647

(383,426)

2,221

Balance as at 31 December 2014

31,854,151

3,091,702

34,945,853

 

Available-for-sale investments are carried at fair values. Where financial assets do not have a quoted market price in an active market and their fair values cannot be reliably measured they are measured at cost less any identified impairment losses at the end of reporting period, in accordance with IAS 39 para 46 (c) exemption.

 

Where there has been a relevant transaction during the year that gives an indication of the fair value of the unlisted shares, the shares are included at that fair value and the increase or decrease in fair value is recognised in the fair value reserve. The "price of recent investment" methodology is used mainly for investments in venture capital companies and includes cost of investment or valuation by reference to a subsequent financing round. Valuation increases above cost are only recognised if that round involved a new external investor and the company is meeting milestones set by investor.

 

(i) Equity investments as at 31 December 2014:

Investee company

Date of initial investment

Value at

1 Jan 2014,

USD

Additions to equity investments during the period, USD

Capitalized consulting and legal fees, USD

Gain/loss from changes in fair value of equity investments, USD

Impairments and Disposals, USD

Internal movements, USD

Value at 31 Dec 2014, USD

Equity stake owned

Unicell

15/09/2011

2,982,471

-

-

-

-

-

2,982,471

10.00%

DepositPhotos

26/07/2011

4,997,285

-

-

-

-

-

4,997,285

27.75%

RollApp

19/08/2011

550,000

50,000

-

-

-

-

600,000

10.00%

Wanelo

21/11/2011

5,369,400

-

-

-

-

-

5,369,400

4.72%

Gild

05/12/2011

170,038

-

-

379,307

-

-

549,345

1.04%

One-Page

06/02/2012

305,367

-

-

(47,015)

(258,352)

-

-

-

ThusFresh

26/03/2012

510,000

-

-

(130,645)

379,355

3.53%

Backblaze

24/07/2012

5,034,439

-

-

1,191,478

-

-

6,225,917

16.45%

UsingMiles

23/08/2012

260,000

-

-

-

(230,727)

(29 273)

-

-

UM Liquidating Trust

15/07/2014

-

-

-

-

-

29 273

29,273

5.89%

Gentoo LABS

17/09/2012

260,000

-

-

-

-

-

260,000

6.25%

Favim Holding

24/10/2012

305,050

-

-

-

-

-

305,050

20.00%

Appsindep

12/11/2012

1,863,685

-

-

-

-

-

1,863,685

19.24%

Virool

29/08/2012

502,275

-

-

-

-

-

502,275

1.69%

Adinch

19/02/2013

1,004,000

600,000

-

796,001

-

-

2,400,001

22.43%

Tracks Media

24/11/2011

341,350

-

-

-

-

-

341,350

6.83%

Wrike

12/06/2012

1,991,150

-

-

-

-

-

1,991,150

4.39%

Graphicly

03/04/2013

485,825

-

-

(125,070)

(220,755)

-

140,000

-

Oriense

27/01/2014

-

59,095

-

-

-

-

59,095

5.45%

E2C

15/02/2014

-

124,732

10,000

2,049

-

-

136,781

5.51%

Drippler

01/05/2014

-

200,000

5,000

97,400

-

-

302,400

1.44%

Weaved

13/06/2014

-

250,000

5,000

-

-

-

255,000

2.44%

Le Tote

21/07/2014

-

200,000

-

(654)

-

251,014

450,360

1.62%

Anews

25/08/2014

-

1,000,000

-

-

-

-

1,000,000

9.41%

Twtrland

01/09/2014

-

150,000

5,000

-

-

-

155,000

3.27%

Drupe Mobile

02/09/2014

-

225,000

5,000

-

-

-

230,000

9.37%

Taxify

15/09/2014

-

185,925

-

8,400

-

134,633

328,958

2.8%

Total

26,932,335

3,044,752

30,000

2,171,251

(709,834)

385,647

31,854,151

 

 

(ii) Convertible loan notes as at 31 December 2014:

Investee company

 

Date of initial investment

Value at 1 Jan 2014,

USD

Additions to convertible note investments during the period, USD

Capitalized consulting and legal fees, USD

Amortized costs, USD

Internal movements, USD

Profit on disposal/ Impairment charge, USD

Disposals, USD

Value at 31 Dec 2014, USD

Term, years

Interest rate, %

Ninua

08/06/2011

500,000

-

-

-

-

-

-

500,000

1.5

5.00%

Pipedrive

30/07/2012

777,266

-

-

(1,914)

-

-

-

775,352

2.0

2.00%

Sharethis

26/03/2013

571,723

-

-

(400)

-

-

-

571,323

5.0

1.09%

KitApps

10/07/2013

202,616

200,000

585

(2,862)

-

-

-

400,339

1.0

2.00%

VitalFields

20/12/2013

141,699

-

-

(4,849)

-

-

-

136,850

1.0

15.00%

Gentoo LABS

21/05/2014

-

100,000

685

(210)

-

-

-

100,475

2.0

0.28%

Whale Path

02/06/2014

-

200,000

5,000

(1,452)

-

-

-

203,548

2.0

5.00%

Quote Roller

11/07/2014

-

400,000

5,000

(1,185)

-

-

-

403,815

2.0

2.00%

Le Tote

21/07/2014

-

250,000

-

-

(250,000)

-

-

-

-

-

Taxify

15/09/2014

-

129,590

5,000

(1,164)

(133,426)

-

-

-

-

-

Total

 

2,193,304

1,279,590

16,270

(14,036)

(383,426)

-

-

3,091,702

 

11 Trade and other receivables

 

At 31 December 2014

At 31 December 2013

USD

USD

Prepayments

6,438

9,767

Interest receivable on promissory notes

152,528

68,151

Interest receivable on deposits

818

1,614

159,784

79,532

 

12 Cash and cash equivalents

 

The cash and cash equivalents as at 31 December 2014 include cash on hand and in banks, deposits, net of outstanding bank overdrafts. The effective interest rate at 31 December 2014 was 0.95%.

 

Cash and cash equivalents comprise the following:

 

At 31 December 2014

At 31 December 2013

USD

USD

Deposits

1,000,000

1,500,000

Bank balances

1,639,070

1,742,269

2,639,070

3,242,269

 

The following table represents an analysis of cash and equivalents by rating agency designation based on Fitch rating or their equivalent:

At 31 December 2014

At 31 December 2013

USD

USD

Bank balances

A rating

1,639,070

1,742,269

1,639,070

1,742,269

Deposits

A rating

1,000,000

1,500,000

1,000,000

1,500,000

2,639,070

3,242,269

 

13 Trade and other payables

 

At 31 December 2014

At 31 December 2013

USD

USD

Directors' fees payable

23,902

40,540

Trade payables

34,874

55,424

Other current liabilities

623

44

Accrued expenses

-

-

59,399

96,008

 

14 Share capital

 

On 31 December 2014 the Company had an authorised share capital of unlimited shares of no par value and had issued share capital of:

At 31 December 2014

At 31 December 2013

 

USD

USD

 

Share capital

31,453,510

26,895,179

 

 

Issued capital comprises:

Number

Number

 

Fully paid ordinary shares

27,744,962

24,977,728

 

Number of shares

Share capital,

USD

Balance at 31 December 2013

24,977,728

26,895,179

Issue of shares

2,767,234

4,558,331

Share buy-back and cancellation

-

-

Balance at 31 December 2014

27,744,962

31,453,510

 

On 29 April 2014, as a result of Alexander Selegenev's exercising his option, the Company allotted 33,334 new ordinary shares of no par value each in the Company to Alexander Selegenev at a price of US$1.00 per share, raising US$33,334.

 

On 20 June 2014, as a result of the Company's senior managers German Kaplun, Alexander Morgulchik and Artyom Inyutin's exercising their options, the Company allotted 1,125,000 ordinary shares, at the exercise price of US$1.40 per share. The share price on the date of exercise was US$1.975 per share.

 

On 22 July 2014, the Company allotted 1,432,431 new ordinary shares of no par value each in the Company to new investors at a price of US$1.85 per share, being a discount of 5.6% over the closing price of the Company's shares on 21 July 2014 and raising US$2.65 million.

 

In December 2013, German Kaplun, Alexander Morgulchik and Artyom Inyutin entered into agreements with the Company to receive all of their 2014 salaries, collectively amounting to US$300,000, in TMT shares on 31 December 2014 rather than monthly in cash. Accordingly, on 31 December 2014, the Company allotted 176,469 ordinary shares of no par value each in the Company at a price of US$1.70 per share (31 December 2013: the Company allotted 187,500 ordinary shares of no par value each in the Company at a price of US$1.60 per share amounting to US$300,000 ).

 

There have been no changes to the Company's share capital between the year-end date and the date of approval of these financial statements.

 

15 Share-based payments

 

For the year ended 31/12/2014

For the year ended 31/12/2013

USD

USD

Share option (compensation expense)

166,282

576,207

Total share-based payment charge

166,282

576,207

 

On 27 April 2011, on the recommendation of the independent directors, the Company granted share options to subscribe for up to 100,000 ordinary shares to Mr. Alexander Selegenev, an executive director of the Company.

 

The terms and conditions of the options granted were as follows:

Options granted to Alexander Selegenev

Date granted

1 January 2011

Number of instruments

100,000

Option life, years

1-3

Exercise price

US$1.00

 

Options granted to Mr. Alexander Selegenev vested as follows:

 

No. of ordinary shares

Exercise Price

Exercise Period

33,333

US$1

31/12/11-30/01/12*

33,333

US$1

31/12/12-30/01/13*

33,334

US$1

31/12/13-30/01/14*

 

* or a period of 30 days starting from the date on which certain circumstances preventing exercise during these periods have ended.

 

As at 31 December 2014 all options for 100,000 ordinary shares had either been exercised by Mr. Alexander Selegenev or lapsed.

 

On 24 October 2012, Board of Directors approved a share option plan (the "Plan") for directors, officers, employees of or consultants to the Company and/or any company directly or indirectly controlled by the Company.

 

Under the Plan, options for a total of 7,500,000 ordinary shares in the Company, representing approximately 30% of the then issued share capital (or 23% of the enlarged share capital at the time, assuming full exercise of the options), could be made available at an exercise price determined by the Board or its remuneration committee, which would not be less than the closing middle market price for the Company's share on AIM on the date of grant as published by or on behalf of the London Stock Exchange plc.

 

Options were to vest on a daily basis over a period of 3 years whilst the option holder remains eligible, and vested options could be exercised on each anniversary of the grant, but if not exercised within 1 year from the allowable date of exercise, would lapse.

 

The following options, without performance conditions, have been granted under the Plan on 24 October 2012:

 

Name

Option Shares

Option Price Year 1

Option Price Year 2

Option Price Year 3

German Kaplun (Employee)

1,125,000

US$1.40

US$1.55

US$1.70

Alexander Morgulchik (Employee)

1,125,000

US$1.40

US$1.55

US$1.70

Alexander Selegenev (Director)

1,125,000

US$1.40

US$1.55

US$1.70

Artyom Inyutin (Employee)

1,125,000

US$1.40

US$1.55

US$1.70

Yuri Mostovoy (Director)

562,500

US$1.40

US$1.55

US$1.70

Alexander Pak (Employee)

300,000

US$1.40

US$1.55

US$1.70

Levan Kavtaradze (Employee)

150,000

US$1.40

US$1.55

US$1.70

TOTAL

5,512,500

 

The fair value of services received in return for share options granted is based on the fair value of share options and warrants granted, measured using the Black-Scholes formula, using the following assumptions:

 

(in USD, except for number of shares and percent)

Option Price Year 1

Option Price Year 2

Option Price Year 3

Number of share options granted

1,837,500

1,837,500

1,837,500

Fair value of share option at date of grant

0.25

0.15

0.09

Share price at date of grant

1.65

1.65

1.65

Exercise price

1.40

1.55

1.70

Expected volatility, per cent

9.39%

9.39%

9.39%

Option life, years

0-1

0-2

0-3

Expected dividends, percent

0

0

0

Risk free interest rate, percent

0.41%

0.41%

0.41%

 

Expected volatility is estimated from the Company's share price performance on AIM.

 

Number of shares

Weighted average exercise price of share options

Outstanding share options at 31 December 2013

5,512,500

1.55

Options exercised during the year ended 31 December 2014

(1,125,000)

1.40

Options expired during the year ended 31 December 2014

(712 500)

1.40

Outstanding share options at 31 December 2014

3,675,000

1.63

Exercisable share options at 31 December 2014

1,837,500

1.55

 

On 20 June 2014, the Company's senior managers German Kaplun, Alexander Morgulchik and Artyom Inyutin each exercised options over 375,000 (in total 1,125,000) ordinary shares, at the exercise price of US$1.40 per share. The share price on the date of exercise was US$1.975 per share.

 

No other options that vested in Year 1 under the Plan were exercised, and those options have now lapsed.

 

16 Reserves

Share-based payment reserve

USD

Fair value reserve

USD

Retained losses

USD

Total

USD

Balance as at 1 January 2013

128,183

2,005,228

(1,336,201)

797,210

Loss for the year

-

-

(1,849,303)

(1,849,303)

Gain from changes in fair value

-

5,932,139

-

5,932,139

Share-based payment charge

576,207

-

-

576,207

Transfer on lapse of share options

(8,420)

-

8,420

-

Balance as at 31 December 2013

695,970

7,937,367

(3,177,084)

5,456,253

Loss for the year

-

-

(1,561,988)

(1,561,988)

Gain from changes in fair value

-

2,171,251

-

2,171,251

Share-based payment charge

166,282

-

-

 166,282

Transfer on exercise of share options

(469,593)

-

469,593

 -

Balance as at 31 December 2014

392,659

10,108,618

(4,269,479)

6,231,798

 

17 Capital management

 

The capital structure of the Company consists of equity share capital, reserves, and retained losses.

 

The Board's policy is to maintain a strong capital base so as to maintain investor and market confidence and to enable the successful future development of the business.

 

The Company is not subject to externally imposed capital requirements.

 

No changes were made to the objectives, policies and process for managing capital during the year.

 

18 Financial risk management and financial instruments

 

The Company has identified the following risks arising from its activities and has established policies and procedures to manage these risks. The Company's principal financial assets are cash and cash equivalents, investments in equity shares, and convertible notes receivable.

 

Credit risk

As at 31 December 2014 the largest exposure to credit risk related to cash and cash equivalents, which was US$2,639,070. The exposure risk is reduced because the counterparties are banks with high credit ratings ("A" Liquidity banks) assigned by international credit rating agencies. The Directors intend to continue to spread the risk by holding the Company's cash reserves in more than one financial institution.

 

(i) Exposure to credit risk

The carrying amount of the following assets represents the maximum credit exposure. The maximum exposure to credit risk asat 31 December is as follows:

At 31 December 2014

At 31 December 2013

USD

USD

Convertible notes receivable

3,091,702

2,193,304

Trade and other receivables

159,784

79,532

Cash and cash equivalents

2,639,070

3,242,269

5,890,556

5,515,105

 

Market risk

The Company's financial assets areclassified as available-for-sale and are measured at fair value. The measurement of the Company's investments in equity shares and convertible notes is largely dependent on the underlying trading performance of the investee companies, but the valuation and other items in the financial statements can also be affected by the interest rate and fluctuations in the exchange rate.

 

Interest rate risk

Changes in interest rates impact primarily cash and cash equivalents by changing either their fair value (fixed rate deposits) or their future cash flows (variable rate deposits). Management does not have a formal policy of determining how much of the Company's exposure should be to fixed or variable rates.

 

At 31 December 2014 the Company had a cash deposit of US$1,000,000, earning a variable rate of interest. The Board of Directors monitors the interest rates available in the market to ensure that returns are maximized.

 

Foreign currency risk management

The Company is exposed to foreign currency risks on investments and salary and director remuneration payments that are denominated in a currency other than the functional currency of the Company. The currency giving rise to this risk is primarily GBP, EUR. The exposure to foreign currency risk as at 31 December 2014 was as follows:

 

For the year ended 31/12/2014

For the year ended 31/12/2014

For the year ended 31/12/2013

For the year ended 31/12/2013

GBP

EUR

GBP

EUR

Current assets

Cash and cash equivalents

207,618

12,026

123,891

13,760

Current liabilities

Trade and other payables

(40,022)

-

(40,756)

-

Net (short) long position

167,596

12,026

83,135

13,760

Net exposure currency

107,647

9,888

50,400

9,964

Net exposure currency (assuming a 10% movement in exchange rates)

150,836

10,823

74,821

12,384

Impact on exchange movements in the statement of comprehensive income

16,760

1,203

8,314

1,376

 

The foreign exchange rates of the USD at 31 December were as follows:

 

31/12/2014

31/12/2013

Currency

British pounds, £

1.5569

1.6495

Euro, €

1.2162

1.3810

 

This analysis assumes that all other variables, in particular interest rates, remain constant.

 

Liquidity risk management

The Company's approach to managing liquidity is to ensure that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company.

 

The Company has low liquidity risk due to maintaining adequate banking facilities, by continuously monitoring actual cash flows and by matching the maturity profiles of financial assets and current liabilities.

 

As at 31 December 2014, the cash and equivalents of the Company were US$2,639,070.

 

The following are the maturities of current liabilities as at 31 December 2014:

 

Carrying amount

Within one year

2-5 years

More than 5 years

USD

USD

USD

USD

Directors' fees payable

23,902

23,902

-

-

Trade payables

34,874

34,874

-

-

Other current liabilities

623

623

-

-

59,399

59,399

-

-

 

19 Related party transactions

 

Since May 2012, TMT's Moscow-based staff have been located in an office that belongs to a company ("Orgtekhnika") controlled by Mr. Alexander Morgulchik and Mr. German Kaplun, who collectively own 22.12% of the issued share capital of TMT and are thus considered related parties. There are currently 5 TMT staff involved working substantially full time on TMT's business. TMT started paying rent from 1 October 2012. Rent was being paid to Orgtekhnika at the rate of US$700 per sq meter per year of space utilised. The board believes this represented a discount from the prevailing market rate for similar office space in Moscow at the time. Together with other related expenses (support personnel, company car, security services, etc.), the total costs to TMT were US$14,384 per month (US$172,608 per year). Following the recent negative developments in the Russian economy and Moscow office rental market in particular, starting from 1 February 2015 these office costs have been reduced to US$7,000 per month.

 

In December 2012, Alexander Morgulchik, German Kaplun and Artyom Inyutin agreed to receive all of their 2013 salaries in TMT shares on 31 December 2014 rather than monthly in cash. The number of shares receivable in each case was fixed at a price of US$1.60 per share. Also in December 2013, Alexander Morgulchik, German Kaplun and Artyom Inyutin agreed to receive all of their 2014 salaries in TMT shares on 31 December 2014 rather than monthly in cash. The number of shares receivable in each case was fixed at a price of US$1.70 (2013: US$1.60) per share.

 

20 Subsequent events

 

In February 2015, TMT's portfolio company Drippler, a mobile tech discovery service, completed a new sizable equity financing round. The transaction represents an uplift of approximately US$97,000 (or 48%) in the fair value of TMT's investment in Drippler, compared to the amount announced as of 30 June 2014.

 

In April 2015, the Company invested US$300,000 in fragrance subscription service ScentBird.

 

21 Control

 

The Company is not controlled by any one party. Details of significant shareholders are shown in the Directors' Report.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PGURACUPAGAU
Date   Source Headline
19th Mar 20247:00 amRNSFinal Results and Notice of AGM
28th Feb 20241:26 pmRNSHoldings in Company
30th Oct 20237:00 amRNSChange of Joint Broker
25th Oct 20237:00 amRNSDirector Dealing
15th Aug 20237:00 amRNSHalf-year Report
23rd May 20233:48 pmRNSResult of AGM
11th Apr 20237:00 amRNSHoldings in Company
28th Mar 20237:00 amRNSFinal Results and Notice of AGM
13th Mar 20235:51 pmRNSUpdate re Silicon Valley Bank
13th Dec 20227:00 amRNSPortfolio Update
8th Dec 20222:58 pmRNSDirector/PDMR Shareholding
7th Oct 20225:30 pmRNSHolding(s) in Company
19th Aug 20227:00 amRNSPDMR and Major Shareholdings
16th Aug 20227:00 amRNSHalf-year Report
23rd May 20226:18 pmRNSResult of AGM and Director Appointment
8th Apr 20221:15 pmRNSPDMR and Major Shareholdings
25th Mar 20227:00 amRNSFinal Results and Notice of AGM
21st Jan 20222:25 pmRNSPDMR and Major Shareholdings
11th Jan 20227:00 amRNSPortfolio Update
2nd Dec 20217:00 amRNSDirector/PDMR Shareholding
11th Nov 202110:00 amRNSBackblaze IPO Pricing Update
1st Nov 20211:00 pmRNSPortfolio Update
19th Oct 202110:45 amRNSPortfolio Update
8th Oct 20215:00 pmRNSHolding(s) in Company
5th Oct 20213:00 pmRNSReceipt of Depositphotos disposal consideration
4th Oct 20215:03 pmRNSResult of the PrimaryBid Offer
1st Oct 20214:36 pmRNSPrimaryBid Offer
1st Oct 20214:30 pmRNSPlacing and Subscription to raise US$18.5 million
17th Sep 20217:00 amRNSPortfolio Update
18th Aug 20217:00 amRNSHalf-year Report
2nd Aug 20214:16 pmRNSSignificant Revaluation
30th Jul 20217:00 amRNSResult of AGM
1st Jul 20217:00 amRNSPortfolio Update
1st Jun 20217:00 amRNSCenkos Growth & Innovation Forum
12th May 202110:00 amRNSPortfolio Update
22nd Apr 20212:28 pmRNSPDMR Shareholdings
21st Apr 20218:27 amRNSDirector/PDMR Shareholding
13th Apr 20216:30 pmRNSDirector/PDMR Shareholding
6th Apr 20218:43 amRNSPDMR and Major Shareholdings
25th Mar 20217:00 amRNSFinal Results and Notice of AGM
17th Feb 20217:00 amRNSChange of Adviser
13th Jan 20214:15 pmRNSDirector/PDMR Shareholding
23rd Dec 20203:00 pmRNSDirector/PDMR Shareholding
21st Dec 20203:30 pmRNSReceipt of US$40.9m re Pipedrive
18th Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSBolt’s EUR150m capital raise and portfolio update
25th Nov 20207:00 amRNSShareholder Loan and Amendment of Bonus Plan
12th Nov 20202:28 pmRNSUS$41m disposal of interest in Pipedrive
16th Oct 20207:00 amRNSPDMR and Major Shareholdings
15th Oct 202012:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.